IN DATAPowered by Deals analysisRankingsEconomic dataMacro-economic indicatorsINSIDE THE DEALImcyse closes €21.3m Series B funding roundImcyse has secured funding to continue developing novel immunotherapies for severe autoimmune diseasesDeals AnalysisYear-on-year deals volume continues to declineA breakdown of deals by region shows that year-on-year pharma industry deals have declinedRankingsWho's leading in Europe in terms of market capOur pharma industry key list brings you the 15 leading biopharma companies in Europe by revenueDeals analysisRankingsEconomic dataMacro-economic indicators02/24/2024 02:03:12
Deals analysis
Rankings
Economic data
Macro-economic indicators